Vor Biopharma Inc.
VOR
$7.53
-$0.15-1.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,848.89% | -5,552.75% | -5.46% | -16.95% | 16.97% |
| Total Depreciation and Amortization | -99.76% | 134.41% | -12.51% | -3.03% | -4.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21,307.24% | 41,133.35% | -8.05% | 39.87% | 12.49% |
| Change in Net Operating Assets | 5,208.08% | 228.76% | 35.97% | 461.49% | -107.81% |
| Cash from Operations | -130.46% | -61.05% | -1.97% | -0.15% | 16.54% |
| Capital Expenditure | -617.65% | -1,588.89% | -102.63% | 35.14% | 92.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -100.00% | -100.00% |
| Cash from Investing | -617.65% | -98.78% | -100.52% | -100.70% | -100.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19,909.91% | 385.00% | -- | 118,285.11% | -71.97% |
| Repurchase of Common Stock | 72.86% | 37.25% | 69.78% | -36.36% | 68.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 52,458.54% | 564,825.81% | -731.25% | 213,044.00% | -76.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.00% | 351.68% | -334.50% | 313.31% | -281.66% |